Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders. (Q42201127)
Jump to navigation
Jump to search
scientific article published on June 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders. |
scientific article published on June 2007 |
Statements
Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders (English)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference